Related Articles
Targeting the mTOR pathway using novel ATP‑competitive inhibitors, Torin1, Torin2 and XL388, in the treatment of glioblastoma
Involvement of mTORC1 and mTORC2 in regulation of glioblastoma multiforme growth and motility
Dual mTOR/PI3K inhibitor NVP‑BEZ235 arrests colorectal cancer cell growth and displays differential inhibition of 4E‑BP1
PP242 suppresses bladder cancer cell proliferation and migration through deactivating the mammalian target of rapamycin complex 2/AKT1 signaling pathway
Targeted inhibition of mTORC2 prevents osteosarcoma cell migration and promotes apoptosis